Company intelligence / Profile preview
Y's AC
Chiyoda-ku, Tokyo, Japanys-ac.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Y's AC is a Japanese biotechnology company focused on developing innovative therapeutic agents for cancer and immune disorders, primarily targeting the CD26 molecule. The company's lead asset, YS110, is a humanized monoclonal antibody that has shown promising safety and efficacy in clinical trials for malignant mesothelioma and other CD26-expressing solid tumors. Spun off from Y's Therapeutics in 2010, Y's AC collaborates with academic institutions like the University of Tokyo and has a strategic partnership with Kissei Pharmaceutical for the development and commercialization of YS110 in Japan. The company also explores the potential of CD26-targeted therapies in treating viral infections such as MERS-CoV and various immune-related conditions.
- Therapeutic areas
- OncologyImmunologyInfectious Diseases
- Modalities
- Monoclonal antibodyHumanized monoclonal antibody
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Kissei PharmaceuticalUniversity of TokyoJapan Agency for Medical Research and Development (AMED)Juntendo University
Beyond the preview
Go deeper on Y's AC.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Y's AC.